Gary Ingenito - 13 May 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Issuer symbol
CPRX
Transactions as of
13 May 2025
Net transactions value
-$4,887,560
Form type
4
Filing time
15 May 2025, 17:00:41 UTC
Previous filing
07 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
INGENITO GARY Chief Med. & Reg. Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Gary Ingenito 15 May 2025 0001279473

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $684,000 +200,000 +290% $3.42 268,873 13 May 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $4,736,000 -200,000 -74% $23.68 68,873 13 May 2025 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $204,160 +44,000 +64% $4.64 112,873 14 May 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $1,039,720 -44,000 -39% $23.63 68,873 14 May 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -200,000 -25% $0.000000 590,282 13 May 2025 Common Stock 200,000 $3.42 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -44,000 -7.5% $0.000000 546,282 14 May 2025 Common Stock 44,000 $4.64 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range between $23.325 and $23.93 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in a range between $23.44 and $24.025 per share.
F4 Options vested in three annual tranches beginning on December 30, 2021.
F5 Options vested in three annual tranches beginning on December 2, 2020.